XENE

NASDAQ HEALTHCARE

Xenon Pharmaceuticals Inc

$37.57

-$0.45 (-1.18%)

Live quote

52w: $36.07 – $72.66

Loading chart…

P/E Ratio—

P/B Ratio2.96

EV/EBITDA—

Debt/Equity—

ROE-27.84%

ROIC—

Revenue Growth—

Gross Margin—

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat patients with neurological disorders in Canada. The company is headquartered in Burnaby, Canada.

Own XENE? Track it here.

Create a free account to add XENE to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account